Mutations in DNMT3A have been implicated in a spectrum of human diseases, particularly hematological malignancies7–11 and developmental disorders, including Tatton-Brown-Rahman syndrome (TBRS)12 and microcephalic dwarfism13. This evidence concerns the gene DNMT3A and Tatton-Brown-Rahman overgrowth syndrome.